CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Top Glove - BVAsg CFD

0.268
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.009
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0264 %
Charges from borrowed part ($-1.06)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0264%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0264 %
Charges from borrowed part ($-1.06)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0181%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency SGD
Margin 20%
Stock exchange Singapore
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.268
Open* 0.268
1-Year Change* -67.55%
Day's Range* 0.268 - 0.268
52 wk Range 0.565-3.43
Average Volume (10 days) 93.393
Average Volume (3 months) 1695.39
Market Cap 7345.36
P/E Ratio 31.794
Shares Outstanding 8007340000
Revenue 5572.35
EPS 0.02815
Dividend (Yield %) 47.933
Beta 1.3208
Next Earnings Date Dec 8, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 29, 2022 0.273 0.005 1.87% 0.268 0.278 0.263
Nov 28, 2022 0.268 -0.005 -1.83% 0.273 0.273 0.268
Nov 25, 2022 0.273 -0.025 -8.39% 0.298 0.298 0.273
Nov 24, 2022 0.293 0.020 7.33% 0.273 0.298 0.273
Nov 23, 2022 0.263 0.000 0.00% 0.263 0.268 0.263
Nov 22, 2022 0.268 -0.010 -3.60% 0.278 0.283 0.263
Nov 21, 2022 0.278 0.010 3.73% 0.268 0.283 0.263
Nov 18, 2022 0.278 0.005 1.83% 0.273 0.278 0.273
Nov 17, 2022 0.273 -0.005 -1.80% 0.278 0.278 0.268
Nov 16, 2022 0.283 0.000 0.00% 0.283 0.293 0.283
Nov 15, 2022 0.283 -0.015 -5.03% 0.298 0.303 0.278
Nov 14, 2022 0.298 0.020 7.19% 0.278 0.298 0.278
Nov 11, 2022 0.278 0.010 3.73% 0.268 0.283 0.268
Nov 10, 2022 0.258 0.010 4.03% 0.248 0.258 0.243
Nov 9, 2022 0.243 -0.005 -2.02% 0.248 0.253 0.238
Nov 8, 2022 0.243 0.010 4.29% 0.233 0.243 0.228
Nov 7, 2022 0.228 0.005 2.24% 0.223 0.228 0.218
Nov 4, 2022 0.223 0.005 2.29% 0.218 0.223 0.213
Nov 3, 2022 0.213 -0.015 -6.58% 0.228 0.233 0.213
Nov 2, 2022 0.233 -0.005 -2.10% 0.238 0.238 0.233

Top Glove Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 2888.51 3409.18 4220.74 4801.14 7237.43 16361.4
Revenue 2888.51 3409.18 4220.74 4801.14 7237.43 16361.4
Cost of Revenue, Total 2292.97 2803.86 3378.37 3917.14 4386.11 5259.34
Gross Profit 595.546 605.319 842.368 883.995 2851.32 11102.1
Total Operating Expense 2473 3034.07 3679.57 4295.28 5036.05 6326.09
Selling/General/Admin. Expenses, Total 211.338 283.702 341.197 427.295 706.044 1211.64
Interest Expense (Income) - Net Operating -17.807 -30.892 -4.312 -13.782 -28.437 -101.975
Unusual Expense (Income) 0 -4.292 -4.664 -1.704 -0.35 0
Other Operating Expenses, Total -13.501 -18.304 -31.022 -33.677 -27.314 -42.911
Operating Income 415.516 375.105 541.169 505.863 2201.38 10035.4
Interest Income (Expense), Net Non-Operating 26.686 9.938 -18.369 -82.275 -35.827 -1.543
Net Income Before Taxes 442.202 385.043 522.8 423.588 2165.55 10033.8
Net Income After Taxes 362.439 330.529 433.206 367.546 1788.83 7823.99
Minority Interest -1.71 0.135 -4.376 -2.868 -10.641 -62.315
Net Income Before Extra. Items 360.729 330.664 428.83 364.678 1778.19 7761.68
Net Income 360.729 330.664 428.83 364.678 1778.19 7761.68
Income Available to Common Excl. Extra. Items 360.729 330.664 428.83 364.678 1752.58 7710.33
Income Available to Common Incl. Extra. Items 360.729 330.664 428.83 364.678 1752.58 7710.33
Diluted Net Income 360.729 330.664 428.83 381.67 1752.58 7710.33
Diluted Weighted Average Shares 7519.46 7598.47 22853.9 8059.91 8015.66 8045.95
Diluted EPS Excluding Extraordinary Items 0.04797 0.04352 0.01876 0.04735 0.21864 0.95829
Dividends per Share - Common Stock Primary Issue 0.02417 0.02417 0.00944 0.025 0.11833 0.582
Diluted Normalized EPS 0.04825 0.04369 0.0189 0.04833 0.22073 0.96257
Dilution Adjustment 16.992
Total Adjustments to Net Income -25.605 -51.35
Q3 2021 Q4 2021 Q1 2021 Q2 2022 Q3 2022
Total revenue 4162.74 2074.88 1584.12 1449.3 1464.64
Revenue 4162.74 2074.88 1584.12 1449.3 1464.64
Total Operating Expense 1558.89 1453.93 1323.57 1336.45 1423.18
Other Operating Expenses, Total 1558.89 1453.93 1323.57 1336.45 1423.18
Operating Income 2603.86 620.959 260.552 112.842 41.469
Interest Income (Expense), Net Non-Operating -0.35 -0.31 -1.707 -0.567 -3.08
Net Income Before Taxes 2603.51 620.649 258.845 112.275 38.389
Net Income After Taxes 2064.43 470.603 202.373 102.336 29.275
Minority Interest -15.599 -10.26 -3.853 -1.57 -1.586
Net Income Before Extra. Items 2048.83 460.343 198.52 100.766 27.689
Net Income 2048.83 460.343 198.52 100.766 27.689
Total Adjustments to Net Income -12.662 -12.943 -12.802 -13.217 -12.397
Income Available to Common Excl. Extra. Items 2036.17 447.4 185.718 87.549 15.292
Income Available to Common Incl. Extra. Items 2036.17 447.4 185.718 87.549 15.292
Diluted Net Income 2036.17 447.4 185.718 87.549 15.292
Diluted Weighted Average Shares 8010.21 8039.19 8010.98 8010.34 8008.65
Diluted EPS Excluding Extraordinary Items 0.2542 0.05565 0.02318 0.01093 0.00191
Dividends per Share - Common Stock Primary Issue 0.127 0.038 0.012 0 0
Diluted Normalized EPS 0.2542 0.05565 0.02318 0.01093 0.00191
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 1336.74 1251.36 1847.83 1779.1 4287.65 4345.76
Cash and Short Term Investments 703.18 446.978 358.911 253.067 2883.19 2508.36
Cash 213.769 230.005 165.197 145.412 1090.51 703.921
Short Term Investments 489.411 216.973 193.714 107.655 1792.69 1804.44
Total Receivables, Net 346.582 460.508 877.715 837.047 805.07 588.226
Accounts Receivable - Trade, Net 326.482 393.433 877.715 562.77 771.104 541.296
Total Inventory 263.679 315.775 505.862 629.896 530.729 1144.7
Prepaid Expenses 8.537 13.502 35.249 34.337 39.368
Other Current Assets, Total 14.76 14.593 105.346 23.838 34.327 65.093
Total Assets 2649.14 2990.18 5297.35 5688.21 8705.96 9782.42
Property/Plant/Equipment, Total - Net 1156.77 1498.49 2104.76 2480.03 3211.69 4169.94
Property/Plant/Equipment, Total - Gross 1908.58 2355.88 0 3549.72 4472.36 5685.03
Accumulated Depreciation, Total -751.81 -857.398 -1069.69 -1260.68 -1515.09
Intangibles, Net 22.805 22.805 1019.64 1015.97 31.628 28.104
Long Term Investments 86.29 162.392 178.819 176.145 174.717 240.861
Other Long Term Assets, Total 46.542 55.138 146.3 236.967 19.589 17.073
Total Current Liabilities 690.909 795.738 1451.57 1591.79 2132.52 2198.49
Accounts Payable 176.493 233.494 280.858 357.057 228.255
Accrued Expenses 51.425 56.546 79.156 273.206 292.364
Notes Payable/Short Term Debt 317.796 314.377 0 905.339 308.182 281.939
Other Current Liabilities, Total 145.195 191.054 68.845 190.452 1186.62 1359.62
Total Liabilities 831.129 934.946 2914.3 3151.25 2539.95 2614.76
Total Long Term Debt 81.637 61.75 1330.36 1379.37 236.012 164.129
Long Term Debt 81.637 61.75 1330.36 1379.16 226.34 146.002
Deferred Income Tax 50.757 68.257 116.305 159.714 141.988 191.2
Minority Interest 7.826 9.201 15.35 17.186 24.866 52.495
Total Equity 1818.01 2055.23 2383.05 2536.96 6166.02 7167.67
Common Stock 627.406 636.644 787.709 788.326 1675.7 1841.65
Additional Paid-In Capital 4.781 0
Retained Earnings (Accumulated Deficit) 1174.2 1373.32 1604.66 1776.97 3154.71 5417.25
Treasury Stock - Common -9.739 -9.739 -9.325 -1.781 -1.519 -1413.27
Unrealized Gain (Loss) -4.307 1.302 2.084 0 1.844
Other Equity, Total 25.676 53.7 0 -28.646 1337.12 1320.19
Total Liabilities & Shareholders’ Equity 2649.14 2990.18 5297.35 5688.21 8705.96 9782.42
Total Common Shares Outstanding 7515.96 7524.89 3834.51 7679.52 8124.57 8006.95
Current Port. of LT Debt/Capital Leases 0.267 882.575 135.986 7.459 36.307
Capital Lease Obligations 0 0 0.205 9.672 18.127
Other Liabilities, Total 0 0.719 3.19 4.557 8.448
Payable/Accrued 500.151
Goodwill, Net 980.691 980.691
May 2021 Aug 2021 Nov 2021 Feb 2022 May 2022
Total Current Assets 7076.45 4345.76 3453.92 2912.76 2551.97
Cash and Short Term Investments 4712.76 2508.36 1817.08 1328.6 1003.68
Cash 1012.52 878.446 894.949 562.461 488.256
Short Term Investments 3700.24 1629.92 922.13 766.143 515.426
Total Receivables, Net 1094.26 572.102 516.923 598.083 709.634
Accounts Receivable - Trade, Net 1094.26 566.299 344.66 396.203 407.418
Total Inventory 1203.08 1144.7 997.032 879.475 744.519
Other Current Assets, Total 66.351 120.585 122.885 106.597 94.133
Total Assets 12368.6 9782.42 9017.49 8675.24 8472.76
Property/Plant/Equipment, Total - Net 4099.72 4169.94 4299.64 4497.22 4656.2
Intangibles, Net 1009.72 1008.79 1007.91 1007.03 1006.16
Long Term Investments 177.516 240.861 240.231 240.605 243.065
Other Long Term Assets, Total 5.192 17.073 15.788 17.627 15.374
Total Current Liabilities 3808.53 2198.49 1702.84 1409.96 1279.69
Payable/Accrued 862.276 692.361 755.018 665.366 597.944
Notes Payable/Short Term Debt 287.02 281.939 264.638 263.89 276.08
Current Port. of LT Debt/Capital Leases 34.613 36.307 46.475 53.661 60.619
Other Current Liabilities, Total 2624.62 1187.88 636.712 427.04 345.044
Total Liabilities 4196.45 2614.76 2112.57 1768.55 1652.63
Total Long Term Debt 178.176 164.129 149.85 131.361 123.167
Long Term Debt 166.948 146.002 133.501 115.321 107.355
Capital Lease Obligations 11.228 18.127 16.349 16.04 15.812
Deferred Income Tax 128.343 191.2 202.327 180.57 200.729
Minority Interest 73.157 52.495 50.282 38.91 40.48
Other Liabilities, Total 8.247 8.448 7.265 7.748 8.57
Total Equity 8172.15 7167.67 6904.92 6906.69 6820.13
Common Stock 1840.87 1841.65 1842.02 1842.14 1842.19
Retained Earnings (Accumulated Deficit) 6405.96 5417.25 5170.49 5168.93 5184.19
Treasury Stock - Common -1424.1 -1413.27 -1413.27 -1413.27 -1413.27
Unrealized Gain (Loss) 1.339 1.844 0.135 -4.392 -7.971
Other Equity, Total 1348.08 1320.19 1305.55 1313.29 1215
Total Liabilities & Shareholders’ Equity 12368.6 9782.42 9017.49 8675.24 8472.76
Total Common Shares Outstanding 8004.4 8006.95 8007.1 8007.16 8007.19
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 442.202 385.043 522.8 423.588 2165.55 10033.8
Cash From Operating Activities 433.706 381.086 341.224 526.191 3455.58 7826.93
Cash From Operating Activities 105.773 106.037 143.613 188.817 241.713 304.933
Non-Cash Items -32.215 16.311 51.358 91.039 36.376 120.633
Cash Taxes Paid 98.469 65.473 51.924 59.786 229.945 1840.08
Cash Interest Paid 5.611 6.314 36.772 79.601 31.456 4.187
Changes in Working Capital -82.054 -126.305 -378.08 -180.934 1008.26 -2636.18
Cash From Investing Activities -34.358 -176.667 -1698.23 -493.463 -2369.5 -1247.9
Capital Expenditures -231.296 -479.252 -458.977 -568.159 -815.915 -1335.32
Other Investing Cash Flow Items, Total 196.938 302.585 -1239.26 74.696 -1553.59 87.425
Cash From Financing Activities -328.028 -205.333 1282.93 -34.565 -42.119 -6902.31
Total Cash Dividends Paid -168.863 -181.729 -196.145 -217.393 -371.804 -5474.07
Issuance (Retirement) of Stock, Net 38.904 4.959 13.472 15.146 167.305 -1364.22
Issuance (Retirement) of Debt, Net -198.069 -28.563 1471.26 170.465 -1104.39 22.875
Foreign Exchange Effects 6.624 16.277 -5.718 2.828 1.273 -6.472
Net Change in Cash 77.944 15.363 -79.795 0.991 1045.23 -329.749
Amortization 1.533 3.681 3.683 3.731
Financing Cash Flow Items -5.655 -2.783 1266.77 -86.892
May 2021 Aug 2021 Nov 2021 Feb 2022 May 2022
Net income/Starting Line 9413.16 10033.8 258.845 371.119 409.508
Cash From Operating Activities 8303.81 7826.93 0.039 -74.434 -44.545
Cash From Operating Activities 230.588 308.664 83.606 169.451 258.442
Non-Cash Items -6.133 120.633 12.667 6.646 21.835
Cash Taxes Paid 458.046 1840.08 532.746 657.066 708.772
Cash Interest Paid 3.575 4.187 1.077 2.018 3.063
Changes in Working Capital -1333.81 -2636.18 -355.079 -621.65 -734.33
Cash From Investing Activities -3113.72 -1247.9 481.093 367.412 351.705
Capital Expenditures -1138.46 -1335.32 -228.047 -496.914 -748.817
Other Investing Cash Flow Items, Total -1975.25 87.425 709.14 864.326 1100.52
Cash From Financing Activities -5399.12 -6902.31 -460.326 -597.944 -690.183
Financing Cash Flow Items -41.993 -86.892 -18.027 -54.752 -164.423
Total Cash Dividends Paid -4033.51 -5474.07 -432.454 -528.556 -528.556
Issuance (Retirement) of Stock, Net -1365.46 -1364.22 0.338 0.449 0.497
Issuance (Retirement) of Debt, Net 41.837 22.875 -10.183 -15.085 2.299
Foreign Exchange Effects 12.505 -6.472 -4.255 -10.455 -6.62
Net Change in Cash -196.526 -329.749 16.551 -315.421 -389.643

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Top Glove Company profile

About Top Glove Corporation Berhad

Top Glove Corporation Bhd. is a Malaysia-based manufacturer of gloves. The Company's segments include Malaysia, Thailand and China. It offers a product range, which includes a non-glove segment comprising condoms, face masks, dental dams, exercise bands and household products, fulfilling demand in both the healthcare and non-healthcare segment. Its gloves product categories include medical, surgical procedure, food and services, cleanroom, and safety and industrial. Its non gloves product categories include medical care, personal care, oral care, home care and industrial care. The Company has manufacturing operations in Malaysia, Thailand, Vietnam and China. Its subsidiaries include Top Glove Sdn Bhd, Eastern Press Sdn Bhd, TG Healthcare Sdn Bhd, TG Medical (U.S.A.), Inc, TG Worldwide Sdn Bhd and Top Glove Engineering Sdn Bhd, among others.

Financial summary

BRIEF: For the six months ended 28 February 2022, Top Glove Corporation Berhad revenues decreased 70% to RM3.03B. Net income applicable to common stockholders decreased 95% to RM273.3M. Revenues reflect Malaysia segment decrease of 69% to RM2.62B, Thailand segment decrease of 71% to RM232.3M, Other segment decrease of 74% to RM158.8M. Net income also reflects Malaysia segment income decrease of 95% to RM306.2M.

Equity composition

01/2007, Scrip Issue, 2 new shares for every 5 shares held. 07/2010, Bonus Issue, 1 new share for every 1 share held

Industry: Medical Supplies

Level 21, Top Glove Tower
16, Persiaran Setia Dagang
SHAH ALAM
SELANGOR 40170
MY

Income Statement

People also watch

BTC/USD

16,496.25 Price
+1.630% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 66.00

US100

11,654.30 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0167%
Short position overnight fee 0.0059%
Overnight fee time 22:00 (UTC)
Spread 1.9

Oil - Crude

78.47 Price
+2.520% 1D Chg, %
Long position overnight fee -0.0139%
Short position overnight fee 0.0007%
Overnight fee time 22:00 (UTC)
Spread 0.04

XRP/USD

0.40 Price
+1.310% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00322

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading